Year: 2025
VANCOUVER, British Columbia, Oct. 10, 2025 (GLOBE NEWSWIRE) — Lupaka Gold Corp. (“Lupaka” or the “Company”) (TSX-V: LPK, FRA: LQP) announces that the Company intends to amend the terms of 2,000,000 outstanding common share purchase warrants of the Company (the “Warrants“) that are set to expire October 28, 2025.
The Company is applying to the TSX Venture Exchange (the “TSXV“) to extend the expiry date of the 2,000,000 Warrants to October 28, 2026. The 2,000,000 Warrants were originally issued on October 28, 2022 as part of the units issued under a private placement. The Warrants have an exercise price of $0.25 per share for a period of 36 months. Since the issuance, no warrants have been exercised. All other terms and conditions of the Warrants will remain the same. The warrant extension is subject to the...
Ignitis Renewables takes over full control of the Curonian Nord offshore wind farm
Written by Customer Service on . Posted in Public Companies.
AB “Ignitis grupė” (hereinafter – the Group) informs that following the National Energy Regulatory Council’s (hereinafter – NERC) approval on 10 October, UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) has signed a sale and purchase agreement with OW Offshore, S.L. (hereinafter – Ocean Winds) for the acquisition of 49% shares in UAB “Offshore wind farm 1”, the company developing the Curonian Nord offshore wind project. The application to change the shareholder structure was submitted to NERC by UAB “Offshore wind farm 1” on 30 September.
Upon closing the transaction, Ignitis Renewables will acquire 49% of the shares at a nominal price. Ignitis Renewables will also secure the project-related work, research data and intellectual property by reimbursing Ocean Winds for its directly incurred project-related costs.
This change will...
Ignitis Renewables takes over full control of the Curonian Nord offshore wind farm
Written by Customer Service on . Posted in Public Companies.
AB “Ignitis grupė” (hereinafter – the Group) informs that following the National Energy Regulatory Council’s (hereinafter – NERC) approval on 10 October, UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) has signed a sale and purchase agreement with OW Offshore, S.L. (hereinafter – Ocean Winds) for the acquisition of 49% shares in UAB “Offshore wind farm 1”, the company developing the Curonian Nord offshore wind project. The application to change the shareholder structure was submitted to NERC by UAB “Offshore wind farm 1” on 30 September.
Upon closing the transaction, Ignitis Renewables will acquire 49% of the shares at a nominal price. Ignitis Renewables will also secure the project-related work, research data and intellectual property by reimbursing Ocean Winds for its directly incurred project-related costs.
This change will...
MAXIMA GRUPĖ Borrows EUR 260 Million from SEB and ING Banks to Redeem Bonds
Written by Customer Service on . Posted in Public Companies.
MAXIMA GRUPĖ Borrows EUR 260 Million from SEB and ING Banks to Redeem Bonds
MAXIMA GRUPĖ, UAB (hereinafter – MAXIMA GRUPĖ) announces that it has signed a short-term 2-year financing agreement for a total amount of EUR 260 million with Skandinaviska Enskilda Banken AB, AB SEB bankas (together EUR 130 million) and ING Belgium SA/NV (EUR 130 million).
The funds received from the banks will be used for the early redemption of the MAXIMA GRUPĖ issued long-term bonds and for its related expenses. The credit agreement concluded with the banks is not secured by performance guarantees or any other pledged assets.
“Through this agreement, we are extending our long-term partnership with SEB, one of the largest banks in the Baltic region. We are also pleased to welcome ING, an international banking and financial services provider and one of the largest...
NOTICE OF EXERCISE OF MAKE WHOLE CALL OPTION
Written by Customer Service on . Posted in Public Companies.
NOTICE OF EXERCISE OF MAKE WHOLE CALL OPTION
MAXIMA GRUPE, UAB(the “Issuer”)1
€240,000,000 6.250 per cent. Notes due 2027(the “Notes”)
(ISIN: XS2485155464) (Common Code: 248515546)
10 October 2025
We refer to the terms and conditions of the Notes (the “Conditions“). Capitalised terms used in this notice that are not otherwise defined have the meaning given to them in the Conditions.
Pursuant to Condition 6(e) (Redemption at the Option of the Issuer (Make Whole)) of the Conditions, the Issuer hereby gives notice to the holders of the Notes that it has elected to redeem all the Notes on 27 October 2025 (the “Make Whole Optional Redemption Date“) at the Make Whole Redemption Price together with interest accrued to, but excluding, and unpaid to the Make Whole Optional Redemption Date.
The Issuer...
Bitfarms Converts Macquarie Debt Facility to $300M Project Financing and Draws Additional $50M to Accelerate HPC/AI Development at Panther Creek Campus
Written by Customer Service on . Posted in Public Companies.
-$300 million facility to fund Phase 1 of Panther Creek data center development with energization expected by YE 2026--On track to break ground on Panther Creek data center in Q4 2025-
This news release constitutes a “designated news release” for the purposes of the Company’s second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023.
TORONTO, Ontario and NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) — Bitfarms Ltd. (Nasdaq/TSX: BITF) (the “Company”), a North American energy and digital infrastructure company, has converted its previously announced private debt facility for up to $300 million from Macquarie Group’s Commodities and Global Markets business (“Macquarie”), to an up to $300 million project-specific financing facility for the development of its...
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
Written by Customer Service on . Posted in Public Companies.
PIPE financing included participation from leading healthcare-focused institutional investors including AIGH Capital Management, Soleus Capital, Nantahala Capital, Diadema Partners, Stonepine Capital Management, ADAR1 Capital Management, and Velan Capital, among others
ASHBURN, Va., Oct. 10, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has entered into a securities purchase agreement with new healthcare focused institutional investors with the potential to raise up to $104.5 million in gross proceeds, including initial upfront funding of $16.5 million and up to an additional $88.0 million upon the potential cash exercise of accompanying warrants at the election of the...
Zacks Small-Cap Research Initiates Coverage on NewGen
Written by Customer Service on . Posted in Public Companies.
BANGKOK, Oct. 10, 2025 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that Zacks Small-Cap Research (“Zacks”) has initiated equity research coverage on the Company. The full equity research report is available on the Zacks website here.
About NewGenNewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge...
ASP Isotopes Inc. to host Institutional Investor Access Event in South Africa from November 11 – 13, 2025
Written by Customer Service on . Posted in Public Companies.
*** Limited places remain available for institutional investors for this previously announced Investor Access Event ***
WASHINGTON, Oct. 10, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Institutional Investor Access Event in South Africa from November 11-13, 2025.
**There is also the possibility of adding an extra day to the trip and visiting the Renergen Virginia Gas Project on November 14th – please let us know if you are also interested in attending that day too. (subject to numbers)**
All investors are invited to request a registration to attend the Institutional Investor Access Event.
ASP...
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
Written by Customer Service on . Posted in Mergers And Acquisitions.
PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the “Merger”) pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 20, 2025 (the “Merger Agreement”).
The parties now expect the Merger to close on October 20, 2025, subject to the satisfaction of all conditions in the Merger Agreement.
About ZimVie
ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm...